Validation of a commercially available SARS-CoV-2 serological immunoassay
Detection Principle
ImmunoAssay-Antibody
Target
IgG and IGA
Testing Method Category
ELISA
Testing Method
Euroimmun AG, Lübeck, Germany, # EI 2606-9601 G and # EI 2606-9601 A
Reported Performance
AUC: 99% (IgG), 97.8% (IgA) ; Specificity: 100% ; Sensitivity: 94% ; PPV: 100% ; NPV: 97%
Sample Size
506 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements